Abstract
Sex differences may assume a key role in condition of impaired glucose metabolism and progression to type 2 diabetes, affecting insulin-dependent processes. However, the presence of sex differences in non-insulin-dependent processes (i.e. glucose effectiveness) has been scarcely investigated. The aim of this study was to detect the presence of sex differences in glucose effectiveness (SG), as assessed by minimal model analysis, in subjects with different degrees of glucose metabolism impairment. Two groups of subjects ranging from normal (NGR, n = 57, males/females: 31/26) to abnormal glucose regulation (AGR, n = 115, males/females 42/73) underwent a 3-h frequently sampled intravenous glucose tolerance test. Minimal model analysis provided SG and its components at zero (GEZI) and at basal (BIE) insulin. Values for SG were 2.52 ± 0.98 10−2 min−1 and 2.81 ± 1.07 10−2 min−1 for males and females in the NGR group, and 2.08 ± 1.21 10−2 min−1 and 2.09 ± 0.98 10−2 min−1 for males and females in the AGR group. No statistically significant difference was found between males and females in both NGR (p = 0.29) and AGR (p = 0.94) groups. Sex differences were not detected for GEZI, which provided the major contribution to SG, either in NGR or AGR group. In conclusion, glucose effectiveness and its components seem to be not affected by sex differences in all glucose tolerance conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kautzky-Willer, A., Harreiter, J., Pacini, G.: Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr. Rev. 37(3), 278–316 (2016)
Tura, A., Pacini, G., Moro, E., Vrbíková, J., Bendlová, B., Kautzky-Willer, A.: Sex- and age-related differences of metabolic parameters in impaired glucose metabolism and type 2 diabetes compared to normal glucose tolerance. Diabetes Res. Clin. Pract. 146, 67–75 (2018)
Baron, A.D., Brechtel, G., Wallace, P., Edelman, S.V.: Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255(6 Pt 1), E769–E774 (1988)
Morettini, M., Di Nardo, F., Fioretti, S., Pacini, G., Tura, A., Burattini, L.: No changes in glucose effectiveness in condition of reduced insulin action but preserved glucose tolerance as assessed by minimal model analysis. In: IFMBE Proceedings, vol. 65, pp. 1057–1060 (2017)
Seufert, J.: SGLT2 inhibitors—an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin. Diab. Metab. Syndr. Obes. Targets Ther. 8, 543–554 (2015)
Ader, M., Pacini, G., Yang, Y.J., Bergman, R.N.: Importance of glucose per se to intravenous glucose tolerance: comparison of the minimal-model prediction with direct measurements. Diabetes 34(11), 1092–1103 (1985)
Morettini, M., Di Nardo, F., Burattini, L., Fioretti, S., Göbl, C., Kautzky-Willer, A., Pacini, G., Tura, A.: Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance. Acta Diabetol. 55(10), 1011–1018 (2018)
Morettini, M., Castriota, C., Göbl, C., Kautzky-Willer, A., Pacini, G., Burattini, L., Tura, A.: Glucose effectiveness from short insulin-modified IVGTT and its application to the study of women with previous gestational diabetes mellitus. Diabetes Metab. J. (in press)
Cavallo-Perin, P., Pacini, G., Cerutti, F., Bessone, A., Condo, C., Sacchetti, L., Piga, A., Pagano, G.: Insulin resistance and hyperinsulinemia in homozygous β-thalassemia. Metabolism 44(3), 281–286 (1995)
Cerutti, F., Sacchetti, C., Bessone, A., Rabbone, I., Cavallo-Perin, P., Pacini, G.: Insulin secretion and hepatic insulin clearance as determinants of hyperinsulinaemia in normotolerant grossly obese adolescents. Acta Paediatr. 87(10), 1045–1050 (1998)
Kautzky-Willer, A., Pacini, G., Ludvik, B., Schernthaner, G., Prager, R.: β-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism 41(12), 1304–1312 (1992)
Kautzky-Willer, A., Pacini, G., Niederle, B., Schernthaner, G., Prager, R.: Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery. Clin. Endocrinol. 37(2), 147–155 (1992)
Kautzky-Willer, A., Thomaseth, K., Clodi, M., Ludvik, B., Waldhäusl, W., Prager, R., Pacini, G.: β-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism 45(4), 486–491 (1996)
Pacini, G., Tonolo, G., Sambataro, M., Maioli, M., Ciccarese, M., Brocco, E., Avogaro, A., Nosadini, R.: Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin–modified IVGTT. Am. J. Physiol. 274(4 Pt.1), E592–E599 (1998)
Pagano, G., Pacini, G., Musso, G., Gambino, R., Mecca, F., Depetris, N., Cassader, M., David, E., Cavallo-Perin, P., Rizzetto, M.: Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association. Hepatology 35(2), 367–372 (2002)
Piccardo, M.G., Pacini, G., Nardi, E., Rosa, M.S., De Vito, R.: Beta-cell response and insulin hepatic extraction in noncirrhotic alcoholic patients soon after withdrawal. Metabolism 43(3), 367–371 (1994)
Piccardo, M.G., Turchetti, G.F., Rosa, M.S., Pacini, G.: Elevated basal insulin secretion and normal dynamic insulin sensitivity in borderline hypertension. Nutr. Metab. Cardiovasc. Dis. 9(5), 244–249 (1999)
Riedl, M., Ludvik, B., Pacini, G., Clodi, M., Kotzmann, H., Wagner, O., Kautzy-Willer, A., Prager, R., Luger, A.: The increased insulin sensitivity in growth hormone deficient adults is reduced by growth hormone replacement therapy. Eur. J. Clin. Invest. 30(9), 771–778 (2000)
Pacini, G., Bergman, R.N.: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 23(2), 113–122 (1986)
Kahn, S.E., Klaff, L.J., Schwartz, M.W., Beard, J.C., Bergman, R.N., Taborsky, G.J., Porte, D.: Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J. Clin. Endocrinol. Metab. 71(4), 994–1002 (1990)
Morettini, M., Di Nardo, F., Ingrillini, L., Fioretti, S., Göbl, C., Kautzky-Willer, A., Tura, A., Pacini, G., Burattini, L.: Glucose effectiveness and its components in relation to body mass index. Eur. J. Clin. Invest. 49(6), e13099 (2019)
Tura, A., Sbrignadello, S., Succurro, E., Groop, L., Sesti, G., Pacini, G.: An empirical index of insulin sensitivity from short IVGTT: validation against the minimal model and glucose clamp indices in patients with different clinical characteristics. Diabetologia 53(1), 144–152 (2010)
Burattini, R., Morettini, M., Di Nardo, F., Boemi, M.: Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data. Med. Biol. Eng. Comput. 49(7), 831–841 (2011)
Di Nardo, F., Mengoni, M., Morettini, M.: MATLAB-implemented estimation procedure for model-based assessment of hepatic insulin degradation from standard intravenous glucose tolerance test data. Comput. Methods Programs Biomed. 110(2), 215–225 (2013)
Acknowledgements
We would like to thank Angelo Avogaro (University of Padova, Italy), Paolo Cavallo–Perin (University of Turin, Italy), Anton Luger and Michaela Riedl (Medical University of Vienna, Austria), and Giovanni Musso (Gradenigo Hospital Turin, Italy), for granting the permission to use their data collected in previous studies.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
The authors declare that they have no conflict of interest.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this paper
Cite this paper
Morettini, M. et al. (2020). Model-Based Assessment of Sex Differences in Glucose Effectiveness and Its Components. In: Henriques, J., Neves, N., de Carvalho, P. (eds) XV Mediterranean Conference on Medical and Biological Engineering and Computing – MEDICON 2019. MEDICON 2019. IFMBE Proceedings, vol 76. Springer, Cham. https://doi.org/10.1007/978-3-030-31635-8_60
Download citation
DOI: https://doi.org/10.1007/978-3-030-31635-8_60
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31634-1
Online ISBN: 978-3-030-31635-8
eBook Packages: EngineeringEngineering (R0)